The effects of saffron (Crocus sativus L.) on mental health parameters and C-reactive protein: A meta-analysis of randomized clinical trials.
暂无分享,去创建一个
Ž. Reiner | F. Kolahdooz | H. Mirzaei | Z. Asemi | A. Ghaderi | H. Banafshe | Omid Asbaghi | Parisa Maleki Dana | Elaheh Amirani
[1] A. Omidi,et al. Clinical and metabolic responses to crocin in patients under methadone maintenance treatment: A randomized clinical trial , 2019, Phytotherapy research : PTR.
[2] M. Berk,et al. Effect of saffron supplementation on symptoms of depression and anxiety: a systematic review and meta-analysis. , 2019, Nutrition reviews.
[3] A. Omidi,et al. The effects of crocin on psychological parameters in patients under methadone maintenance treatment: a randomized clinical trial , 2019, Substance Abuse Treatment, Prevention, and Policy.
[4] M. Zilaee,et al. An evaluation of the effect of saffron supplementation on the antibody titer to heat-shock protein (HSP) 70, hsCRP and spirometry test in patients with mild and moderate persistent allergic asthma: A triple-blind, randomized placebo-controlled trial. , 2018, Respiratory medicine.
[5] S. Akhondzadeh,et al. The effects of alcoholic extract of saffron (Crocus satious L.) on mild to moderate comorbid depression-anxiety, sleep quality, and life satisfaction in type 2 diabetes mellitus: A double-blind, randomized and placebo-controlled clinical trial. , 2018, Complementary therapies in medicine.
[6] P. Hegyi,et al. The Efficacy of Saffron in the Treatment of Mild to Moderate Depression: A Meta-analysis , 2018, Planta Medica.
[7] H. Qiu,et al. Comparative efficacy and safety of Crocus sativus L. for treating mild to moderate major depressive disorder in adults: a meta-analysis of randomized controlled trials , 2018, Neuropsychiatric disease and treatment.
[8] F. Jalali,et al. The Effect of Saffron on Depression among Recovered Consumers of Methamphetamine Living with HIV/AIDS , 2018, Substance use & misuse.
[9] A. Avan,et al. Anti-Inflammatory Effect of Crocus sativus on Serum Cytokine Levels in Subjects with Metabolic Syndrome: A Randomized, Double-Blind, Placebo- Controlled Trial. , 2018, Current clinical pharmacology.
[10] A. Sahebkar,et al. Saffron in the treatment of depression, anxiety and other mental disorders: Current evidence and potential mechanisms of action. , 2018, Journal of affective disorders.
[11] S. Akhondzadeh,et al. Efficacy of Crocus sativus (saffron) in treatment of major depressive disorder associated with post-menopausal hot flashes: a double-blind, randomized, placebo-controlled trial , 2018, Archives of Gynecology and Obstetrics.
[12] A. Sahraian,et al. Saffron improved depression and reduced homocysteine level in patients with major depression: A Randomized, double-blind study , 2017, Avicenna journal of phytomedicine.
[13] S. Eslami,et al. A double-blind, randomized, placebo-controlled trial of saffron stigma (Crocus sativus L.) in mothers suffering from mild-to-moderate postpartum depression. , 2017, Phytomedicine : international journal of phytotherapy and phytopharmacology.
[14] S. Akhondzadeh,et al. Effects of Saffron on Cognition, Anxiety, and Depression in Patients Undergoing Coronary Artery Bypass Grafting: A Randomized Double-Blind Placebo-Controlled Trial. , 2017, Journal of alternative and complementary medicine.
[15] S. R. Jahromi,et al. Effect of Saffron ( Crocus sativus L.) as an Add-On Therapy to Sertraline in Mild to Moderate Generalized Anxiety Disorder: A Double Blind Randomized Controlled Trial , 2017 .
[16] M. Jafarabadi,et al. Effects of Saffron Aqueous Extract and Its Main Constituent, Crocin, on Health-Related Quality of Life, Depression, and Sexual Desire in Coronary Artery Disease Patients: A Double-Blind, Placebo-Controlled, Randomized Clinical Trial , 2017 .
[17] K. Abnous,et al. Protective effect of crocin on BPA-induced liver toxicity in rats through inhibition of oxidative stress and downregulation of MAPK and MAPKAP signaling pathway and miRNA-122 expression. , 2017, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.
[18] M. Ghayour-Mobarhan,et al. The effects of crocin on the symptoms of depression in subjects with metabolic syndrome. , 2017, Advances in clinical and experimental medicine : official organ Wroclaw Medical University.
[19] Gavin Beccaria,et al. affron® a novel saffron extract (Crocus sativus L.) improves mood in healthy adults over 4 weeks in a double-blind, parallel, randomized, placebo-controlled clinical trial. , 2017, Complementary therapies in medicine.
[20] C. Shapiro,et al. Cognitive Behavioral Insomnia Therapy for Those With Insomnia and Depression: A Randomized Controlled Clinical Trial , 2017, Sleep.
[21] R. Baldessarini,et al. Morbidity in Depressive Disorders , 2017, Psychotherapy and Psychosomatics.
[22] A. Ghajar,et al. Crocus sativus L. versus Citalopram in the Treatment of Major Depressive Disorder with Anxious Distress: A Double-Blind, Controlled Clinical Trial , 2016, Pharmacopsychiatry.
[23] A. Sahraian,et al. Study the effects of saffron on depression and lipid profiles: A double blind comparative study. , 2016, Asian journal of psychiatry.
[24] K. Abnous,et al. Protective effect of crocin against apoptosis induced by subchronic exposure of the rat vascular system to diazinon , 2016, Toxicology and industrial health.
[25] M. Mazidi,et al. A double-blind, randomized and placebo-controlled trial of Saffron (Crocus sativus L.) in the treatment of anxiety and depression , 2016, Journal of complementary & integrative medicine.
[26] E. Tamaddonfard,et al. Effects of crocin and safranal, saffron constituents, on the formalin-induced orofacial pain in rats , 2015, Avicenna journal of phytomedicine.
[27] A. Talaei,et al. Crocin, the main active saffron constituent, as an adjunctive treatment in major depressive disorder: a randomized, double-blind, placebo-controlled, pilot clinical trial. , 2015, Journal of affective disorders.
[28] Kanako Ichikura,et al. Efficacy and acceptability of group cognitive behavioral therapy for depression: a systematic review and meta-analysis. , 2014, Journal of affective disorders.
[29] H. Hosseinzadeh,et al. Effect of Crocus sativus L. (Saffron) on Coagulation and Anticoagulation Systems in Healthy Volunteers , 2014, Phytotherapy research : PTR.
[30] S. Akhondzadeh,et al. A randomized, double-blind, clinical trial comparing the efficacy and safety of Crocus sativus L. with fluoxetine for improving mild to moderate depression in post percutaneous coronary intervention patients. , 2014, Journal of affective disorders.
[31] S. Anton,et al. Saffron (Crocus sativus L.) and major depressive disorder: a meta-analysis of randomized clinical trials. , 2013, Journal of integrative medicine.
[32] G. Griebel,et al. 50 years of hurdles and hope in anxiolytic drug discovery , 2013, Nature Reviews Drug Discovery.
[33] M. Maj. Validity and clinical utility of the current operational characterization of major depression , 2012, International Review of Psychiatry.
[34] R. Hirschfeld. Depression epidemiology and its treatment evolution. , 2012, The Journal of clinical psychiatry.
[35] J. Sterne,et al. The Cochrane Collaboration’s tool for assessing risk of bias in randomised trials , 2011, BMJ : British Medical Journal.
[36] L. Hedges,et al. Introduction to Meta‐Analysis , 2009, International Coaching Psychology Review.
[37] S. Akhondzadeh,et al. Crocus sativus L. (saffron) in the treatment of premenstrual syndrome: a double‐blind, randomised and placebo‐controlled trial , 2008, BJOG : an international journal of obstetrics and gynaecology.
[38] S. Akhondzadeh,et al. Comparison of petal of Crocus sativus L. and fluoxetine in the treatment of depressed outpatients: A pilot double-blind randomized trial , 2007, Progress in Neuro-psychopharmacology and Biological Psychiatry.
[39] Raghu Kacker,et al. Random-effects model for meta-analysis of clinical trials: an update. , 2007, Contemporary clinical trials.
[40] S. Akhondzadeh,et al. Crocus sativus L. (petal) in the treatment of mild-to-moderate depression: a double-blind, randomized and placebo-controlled trial. , 2006, Phytomedicine : international journal of phytotherapy and phytopharmacology.
[41] S. Akhondzadeh,et al. Hydro-alcoholic extract of Crocus sativus L. versus fluoxetine in the treatment of mild to moderate depression: a double-blind, randomized pilot trial. , 2005, Journal of ethnopharmacology.
[42] S. Akhondzadeh,et al. Crocus sativus L. in the treatment of mild to moderate depression: a double‐blind, randomized and placebo‐controlled trial , 2004, Phytotherapy research : PTR.
[43] P. Tyrer. The case for cothymia: mixed anxiety and depression as a single diagnosis , 2001, British Journal of Psychiatry.
[44] M. Recio,et al. An Update Review of Saffron and its Active Constituents , 1996 .
[45] L. Judd. Mood disorders in the general population represent an important and worldwide public health problem , 1995, International clinical psychopharmacology.
[46] A. Feizi,et al. Effects of Cinnamon, Cardamom, Saffron, and Ginger Consumption on Markers of Glycemic Control, Lipid Profile, Oxidative Stress, and Inflammation in Type 2 Diabetes Patients. , 2014, The review of diabetic studies : RDS.
[47] D. Moher,et al. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. , 2009, Journal of clinical epidemiology.
[48] C. Zheng,et al. Antidepressant properties of bioactive fractions from the extract of Crocus sativus L. , 2009, Journal of Natural Medicines.
[49] A. Hensel,et al. Saffron in phytotherapy: Pharmacology and clinical uses , 2007, Wiener Medizinische Wochenschrift.
[50] S. Akhondzadeh,et al. Bmc Complementary and Alternative Medicine Comparison of Crocus Sativus L. and Imipramine in the Treatment of Mild to Moderate Depression: a Pilot Double-blind Randomized Trial [isrctn45683816] , 2004 .
[51] D. Kyriakidis,et al. Croscus sativus-biological active constitutents , 2002 .
[52] H. Hosseinzadeh,et al. STUDY OF ANTIDEPRESSANT EFFECT OF AQUEOUS AND ETHANOLIC EXTRACT OF CROCUS SATIVUS IN MICE , 2001 .